Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
EA
|
Joel Linzner
EVP Worldwide Business Affairs |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 10.32% |
$348,640
$87.16 p/Share
|
Mar 01
2017 |
NVDA
|
Michael Byron
Principal Accounting Officer |
SELL
Open market or private sale
|
Direct | 750 Reduced 0.47% |
$76,567
$102.09 p/Share
|
Mar 01
2017 |
CMCSA
|
Neil Smit
Sr. EVP |
SELL
Open market or private sale
|
Direct | 33,000 Reduced 30.68% |
$1,241,460
$37.62 p/Share
|
Mar 01
2017 |
INTU
|
Henry Tayloe Stansbury
EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 3,742 Reduced 84.81% |
$468,611
$125.23 p/Share
|
Mar 01
2017 |
NEM
|
Stephen P Gottesfeld
EVP and Chief S&EA Officer |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 6.03% |
$336,500
$33.65 p/Share
|
Mar 01
2017 |
NEM
|
Gary J Goldberg
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 0.65% |
$33,740
$33.74 p/Share
|
Mar 01
2017 |
NEM
|
Scott P Lawson
EVP&Chief Integration Officer |
SELL
Open market or private sale
|
Direct | 4,500 Reduced 6.65% |
$151,830
$33.74 p/Share
|
Mar 01
2017 |
NCLH
|
Andrew Stuart
Pres. & CEO of NCL |
SELL
Open market or private sale
|
Direct | 70,000 Reduced 17.42% |
$3,578,400
$51.12 p/Share
|
Mar 01
2017 |
AMP
|
John Robert Woerner
Pres Ins & Chief Strat Officer |
SELL
Open market or private sale
|
Direct | 5,337 Reduced 18.93% |
$718,200
$134.57 p/Share
|
Mar 01
2017 |
COF
|
Yajnik Sanjiv
President, Financial Services |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 5.86% |
$950,200
$95.02 p/Share
|
Mar 01
2017 |
COF
|
Richard Scott Blackley
Senior Advisor |
SELL
Open market or private sale
|
Direct | 3,507 Reduced 7.55% |
$333,165
$95.0 p/Share
|
Mar 01
2017 |
SNX
|
Dennis Polk
Hyve Solutions Executive |
SELL
Open market or private sale
|
Direct | 498 Reduced 1.12% |
$59,322
$119.12 p/Share
|
Mar 01
2017 |
SNX
|
Dennis Polk
Hyve Solutions Executive |
SELL
Open market or private sale
|
Direct | 2,002 Reduced 4.31% |
$240,761
$120.26 p/Share
|
Mar 01
2017 |
PLNT
|
Dorvin D Lively
President |
SELL
Open market or private sale
|
Direct | 2,469 Reduced 100.0% |
$54,318
$22.0 p/Share
|
Mar 01
2017 |
PRTA
|
Dennis J. Selkoe |
SELL
Open market or private sale
|
Direct | 3,500 Reduced 55.16% |
$207,375
$59.25 p/Share
|
Mar 01
2017 |
PRTA
|
Arthur W Homan
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 3,125 Reduced 100.0% |
$185,250
$59.28 p/Share
|
Mar 01
2017 |
PRTA
|
Gene G. Kinney
President and CEO |
SELL
Open market or private sale
|
Direct | 25,163 Reduced 90.01% |
$1,528,904
$60.76 p/Share
|
Mar 01
2017 |
TSLA
|
Kimbal Musk
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 1.47% |
$635,575
$254.23 p/Share
|
Mar 01
2017 |
PEN
|
Robert D. Evans
EVP, Gen. Counsel & Secretary |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 1.99% |
$400,150
$80.03 p/Share
|
Mar 01
2017 |
PFGC
|
Blackstone Holdings Iii L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 13,133,201 Reduced 48.36% |
$306,003,573
$23.3 p/Share
|
Mar 01
2017 |
RARX
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 7,778 Reduced 0.32% |
$162,638
$20.91 p/Share
|
Mar 01
2017 |
WSO
|
United Technologies Corp /De/
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 4,235,685 Reduced 100.0% |
$595,876,135
$140.68 p/Share
|
Feb 28
2017 |
NEM
|
E Randall Engel
EVP, Strategic Development |
SELL
Open market or private sale
|
Direct | 12,720 Reduced 4.62% |
$435,278
$34.22 p/Share
|
Feb 28
2017 |
URI
|
Singleton B Mcallister
Director |
SELL
Open market or private sale
|
Direct | 3,300 Reduced 16.76% |
$422,532
$128.04 p/Share
|
Feb 28
2017 |
PEP
|
Ramon Laguarta
Chairman and CEO |
SELL
Open market or private sale
|
Direct | 23,585 Reduced 17.01% |
$2,571,944
$109.05 p/Share
|
Feb 28
2017 |
DHR
|
Brian W Ellis
Senior Vice President - GC |
SELL
Open market or private sale
|
Direct | 983 Reduced 13.73% |
$84,538
$86.0 p/Share
|
Feb 28
2017 |
DJCO
|
John Patrick Et Al Guerin
Director |
SELL
Open market or private sale
|
Indirect | 100 Reduced 0.07% |
$21,400
$214.0 p/Share
|
Feb 28
2017 |
IBCP
|
Charles C Van Loan
Director |
SELL
Open market or private sale
|
Direct | 16,993 Reduced 22.26% |
$368,238
$21.67 p/Share
|
Feb 28
2017 |
SQ
|
Khosla Ventures Iii, L.P. |
SELL
Open market or private sale
|
Indirect | 300,000 Reduced 100.0% |
$5,232,000
$17.44 p/Share
|
Feb 28
2017 |
HZNP
|
Robert Carey
EVP, Chief Business Officer |
SELL
Open market or private sale
|
Indirect | 1,808 Reduced 1.42% |
$29,796
$16.48 p/Share
|
Feb 28
2017 |
PRTA
|
Gene G. Kinney
President and CEO |
SELL
Open market or private sale
|
Direct | 3,796 Reduced 57.61% |
$227,760
$60.0 p/Share
|
Feb 28
2017 |
JNJ
|
Ronald A Kapusta
Controller, CAO |
SELL
Open market or private sale
|
Direct | 14,543 Reduced 32.68% |
$1,777,882
$122.25 p/Share
|
Feb 28
2017 |
JNJ
|
Gary J Pruden
Exec VP, WW Chair, Med Devices |
SELL
Open market or private sale
|
Direct | 16,299 Reduced 27.2% |
$1,991,901
$122.21 p/Share
|
Feb 28
2017 |
ABBV
|
Thomas A. Hurwich
VP, Controller |
SELL
Open market or private sale
|
Direct | 2,311 Reduced 3.32% |
$143,028
$61.89 p/Share
|
Feb 28
2017 |
ABT
|
Joseph J Manning
EXECUTIVE VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 744 Reduced 3.13% |
$33,450
$44.96 p/Share
|
Feb 28
2017 |
ABT
|
Hubert L Allen
EXECUTIVE VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 857 Reduced 0.84% |
$38,574
$45.01 p/Share
|
Feb 28
2017 |
ABT
|
Roger Bird
SENIOR VICE PRESIDENT |
SELL
Open market or private sale
|
Direct | 1,601 Reduced 2.74% |
$72,077
$45.02 p/Share
|
Feb 28
2017 |
ABT
|
Heather L Mason
Executive Vice President |
SELL
Open market or private sale
|
Direct | 1,912 Reduced 3.1% |
$86,059
$45.01 p/Share
|
Feb 28
2017 |
ABT
|
Jaime Contreras
Senior Vice President |
SELL
Open market or private sale
|
Direct | 13,155 Reduced 22.34% |
$592,107
$45.01 p/Share
|
Feb 28
2017 |
RARX
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 7,847 Reduced 0.32% |
$163,688
$20.86 p/Share
|
Feb 28
2017 |
NEM
|
E Randall Engel
EVP, Strategic Development |
SELL
Open market or private sale
|
Direct | 2,356 Reduced 1.14% |
$84,392
$35.82 p/Share
|
Feb 27
2017 |
IBCP
|
Charles C Van Loan
Director |
SELL
Open market or private sale
|
Direct | 10,417 Reduced 12.01% |
$228,341
$21.92 p/Share
|
Feb 27
2017 |
NP
|
Armin Schwinn
SVP, Mng Dir, Neenah Germany |
SELL
Open market or private sale
|
Direct | 3,416 Reduced 78.62% |
$265,150
$77.62 p/Share
|
Feb 27
2017 |
NP
|
Steven S Heinrichs
SVP, General Counsel & Sec |
SELL
Open market or private sale
|
Direct | 6,010 Reduced 26.95% |
$454,476
$75.62 p/Share
|
Feb 27
2017 |
SNPS
|
Sudhindra Kankanwadi
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 9,499 Reduced 82.0% |
$685,543
$72.17 p/Share
|
Feb 27
2017 |
LLY
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct | 225,000 Reduced 0.18% |
$18,688,499
$83.06 p/Share
|
Feb 27
2017 |
INTU
|
Brad D Smith
Director |
SELL
Open market or private sale
|
Direct | 103,445 Reduced 33.18% |
$13,067,172
$126.32 p/Share
|
Feb 27
2017 |
ARE
|
Thomas J Andrews
Co-President |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 4.03% |
$603,000
$120.6 p/Share
|
Feb 27
2017 |
PRTA
|
Christopher S Henney
Director |
SELL
Open market or private sale
|
Direct | 5,989 Reduced 100.0% |
$342,331
$57.16 p/Share
|
Feb 27
2017 |
HD
|
Ann Marie Campbell
Senior EVP |
SELL
Open market or private sale
|
Direct | 7,000 Reduced 10.74% |
$1,017,030
$145.29 p/Share
|
Feb 27
2017 |